<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Vet Med Sci</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2053-1095</journal-id><journal-id journal-id-type="publisher-id">VMS3</journal-id><journal-title-group><journal-title>Veterinary Medicine and Science</journal-title></journal-title-group><issn pub-type="epub">2053-1095</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29851307</article-id><article-id pub-id-type="pmc">5980167</article-id><article-id pub-id-type="doi">10.1002/vms3.95</article-id><article-id pub-id-type="publisher-id">VMS395</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Antibody response to Influenza booster vaccination in Franches‐Montagnes stallions supplemented with Equi‐Strath<sup>®</sup>: a randomized trial</article-title><alt-title alt-title-type="left-running-head">H.A. van Dorland <italic>et al</italic>.</alt-title></title-group><contrib-group><contrib id="vms395-cr-0001" contrib-type="author"><name><surname>van Dorland</surname><given-names>Hendrika A.</given-names></name><xref ref-type="aff" rid="vms395-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="vms395-cr-0002" contrib-type="author"><name><surname>Zanoni</surname><given-names>Reto</given-names></name><xref ref-type="aff" rid="vms395-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="vms395-cr-0003" contrib-type="author"><name><surname>Gerber</surname><given-names>Vinzenz</given-names></name><xref ref-type="aff" rid="vms395-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="vms395-cr-0004" contrib-type="author"><name><surname>Jeannerat</surname><given-names>Elise</given-names></name><xref ref-type="aff" rid="vms395-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="vms395-cr-0005" contrib-type="author"><name><surname>Wiederkehr</surname><given-names>Danja</given-names></name><xref ref-type="aff" rid="vms395-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="vms395-cr-0006" contrib-type="author" corresp="yes"><name><surname>Burger</surname><given-names>Dominik</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0834-5161</contrib-id><address><email>dominik.burger@vetsuisse.unibe.ch</email></address><xref ref-type="aff" rid="vms395-aff-0003">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="vms395-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">School of Agricultural, Forest and Food Sciences</named-content>
<institution>Bern University of Applied Sciences</institution>
<named-content content-type="city">Zollikofen</named-content>
<country country="CH">Switzerland</country>
</aff><aff id="vms395-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Institute of Virology and Immunology</named-content>
<institution>Vetsuisse Faculty University of Bern</institution>
<named-content content-type="city">Bern</named-content>
<country country="CH">Switzerland</country>
</aff><aff id="vms395-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Swiss Institute of Equine Medicine</named-content>
<institution>University of Bern, and Agroscope</institution>
<named-content content-type="city">Avenches</named-content>
<country country="CH">Switzerland</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label>Correspondence: Dominik Burger, Swiss Institute of Equine Medicine ISME, Les Longs‐Prés 1, 1580 Avenches, Switzerland. E<italic>‐</italic>mail<italic>:</italic><email>dominik.burger@vetsuisse.unibe.ch</email></corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>2</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2018</year></pub-date><volume>4</volume><issue>2</issue><issue-id pub-id-type="doi">10.1002/vms3.2018.4.issue-2</issue-id><fpage>133</fpage><lpage>139</lpage><permissions><copyright-statement content-type="article-copyright">© 2018 The Authors. <italic>Veterinary Medicine and Science</italic> Published by John Wiley &amp; Sons Ltd.</copyright-statement><license license-type="creativeCommonsBy"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:VMS3-4-133.pdf"></self-uri><abstract id="vms395-abs-0001"><title><offsets xml_i="5145" xml_f="5153" txt_i="11" txt_f="19">Abstract</offsets></title><p><offsets xml_i="5164" xml_f="5174" txt_i="20" txt_f="30">Bio‐Strath</offsets><sup><bold><offsets xml_i="5185" xml_f="5186" txt_i="30" txt_f="31">®</offsets></bold></sup><offsets xml_i="5199" xml_f="5322" txt_i="31" txt_f="154"> is a plasmolyzed yeast product enriched with herbs, malt, honey and orange juice. In this study, the effect of Equi‐Strath</offsets><sup><offsets xml_i="5327" xml_f="5328" txt_i="154" txt_f="155">®</offsets></sup><offsets xml_i="5334" xml_f="5506" txt_i="155" txt_f="327">, the adapted product for horses, on the equine immune system was evaluated. A routine influenza booster vaccination was used as a model to study the effects of Equi‐Strath</offsets><sup><offsets xml_i="5511" xml_f="5512" txt_i="327" txt_f="328">®</offsets></sup><offsets xml_i="5518" xml_f="5679" txt_i="328" txt_f="489"> supplementation on the immune response. Twenty healthy Franches‐Montagnes stallions with pre‐existing antibody levels were randomly divided into a study group (</offsets><styled-content style="fixed-case"><offsets xml_i="5714" xml_f="5716" txt_i="489" txt_f="491">SG</offsets></styled-content><offsets xml_i="5733" xml_f="5734" txt_i="491" txt_f="492">,</offsets><italic><offsets xml_i="5742" xml_f="5744" txt_i="492" txt_f="494"> n</offsets></italic><offsets xml_i="5753" xml_f="5806" txt_i="494" txt_f="547"> = 10) receiving 0.06 mL/kg bodyweight of Equi‐Strath</offsets><sup><bold><offsets xml_i="5817" xml_f="5818" txt_i="547" txt_f="548">®</offsets></bold></sup><offsets xml_i="5831" xml_f="5854" txt_i="548" txt_f="571">, and a control group (</offsets><styled-content style="fixed-case"><offsets xml_i="5889" xml_f="5891" txt_i="571" txt_f="573">CG</offsets></styled-content><offsets xml_i="5908" xml_f="5909" txt_i="573" txt_f="574">,</offsets><italic><offsets xml_i="5917" xml_f="5919" txt_i="574" txt_f="576"> n</offsets></italic><offsets xml_i="5928" xml_f="6328" txt_i="576" txt_f="976"> = 10), receiving the same amount of placebo, daily. The supplement and placebo were given from week 1 until week 14 of the trial. After 10 weeks, the horses were vaccinated with a commercial vaccine containing equine influenza strains of the H3N8 subtype. Antibody titres in blood were measured at day 0 before vaccination, and 14 and 32 days after vaccination. In addition, a complete blood count (</offsets><styled-content style="fixed-case"><offsets xml_i="6363" xml_f="6366" txt_i="976" txt_f="979">CBC</offsets></styled-content><offsets xml_i="6383" xml_f="6573" txt_i="979" txt_f="1169">) was performed on day 0 and day 32. A linear increase of haemagglutination inhibition titres in both groups was observed after vaccination, but with no difference between treatment groups. </offsets><styled-content style="fixed-case"><offsets xml_i="6608" xml_f="6611" txt_i="1169" txt_f="1172">CBC</offsets></styled-content><offsets xml_i="6628" xml_f="6706" txt_i="1172" txt_f="1250"> components remained unaffected by treatment. In conclusion, daily Equi‐Strath</offsets><sup><offsets xml_i="6711" xml_f="6712" txt_i="1250" txt_f="1251">®</offsets></sup><offsets xml_i="6718" xml_f="6854" txt_i="1251" txt_f="1387"> supplementation did not affect the adaptive immune response in stallions after a routine commercial H3N8 influenza booster vaccination.</offsets></p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="vms395-kwd-0001">equine</kwd><kwd id="vms395-kwd-0002">plasmolyzed yeast</kwd><kwd id="vms395-kwd-0003">vaccination</kwd><kwd id="vms395-kwd-0004">influenza</kwd><kwd id="vms395-kwd-0005">antibody titre</kwd></kwd-group><funding-group><award-group><funding-source>Bio‐Strath</funding-source></award-group><award-group><funding-source>ISMEquine Research, the School of Agricultural, Forest and Food Sciences (HAFL)</funding-source></award-group></funding-group><counts><fig-count count="2"></fig-count><table-count count="1"></table-count><page-count count="7"></page-count><word-count count="3346"></word-count></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>vms395</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May 2018</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.4.0 mode:remove_FC converted:31.05.2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="vms395-sec-0001"><title><offsets xml_i="8132" xml_f="8144" txt_i="1395" txt_f="1407">Introduction</offsets></title><p><offsets xml_i="8155" xml_f="8333" txt_i="1408" txt_f="1582">Successful equine influenza vaccination in horses stimulates an immune response, resulting in an increase of the antigen‐specific antibody production (Van Maanen &amp; Cullinane </offsets><xref rid="vms395-bib-0018" ref-type="ref"><offsets xml_i="8376" xml_f="8380" txt_i="1582" txt_f="1586">2002</offsets></xref><offsets xml_i="8387" xml_f="8477" txt_i="1586" txt_f="1676">). The extent of the immune response, however, may be affected by several factors. Folsom </offsets><italic><offsets xml_i="8485" xml_f="8490" txt_i="1676" txt_f="1681">et al</offsets></italic><offsets xml_i="8499" xml_f="8502" txt_i="1681" txt_f="1684">. (</offsets><xref rid="vms395-bib-0005" ref-type="ref"><offsets xml_i="8545" xml_f="8549" txt_i="1684" txt_f="1688">2001</offsets></xref><offsets xml_i="8556" xml_f="8710" txt_i="1688" txt_f="1842">) observed how exercise alters the immune response to equine influenza virus and may increase susceptibility to infection in ponies. In addition, Horohov </offsets><italic><offsets xml_i="8718" xml_f="8723" txt_i="1842" txt_f="1847">et al</offsets></italic><offsets xml_i="8732" xml_f="8735" txt_i="1847" txt_f="1850">. (</offsets><xref rid="vms395-bib-0007" ref-type="ref"><offsets xml_i="8778" xml_f="8782" txt_i="1850" txt_f="1854">1999</offsets></xref><offsets xml_i="8789" xml_f="9188" txt_i="1854" txt_f="2253">) concluded that older horses had a reduced immune function, but were nevertheless more resistant to exercise‐induced immune suppression than younger horses. Dietary effects on the immune response in horses have also been reported. For instance, it was shown by several groups that dietary consumption of polyunsaturated fatty acids (PUFAs) can positively affect the immune system in horses (Curtis </offsets><italic><offsets xml_i="9196" xml_f="9201" txt_i="2253" txt_f="2258">et al</offsets></italic><offsets xml_i="9210" xml_f="9212" txt_i="2258" txt_f="2260">. </offsets><xref rid="vms395-bib-0004" ref-type="ref"><offsets xml_i="9255" xml_f="9259" txt_i="2260" txt_f="2264">2000</offsets></xref><offsets xml_i="9266" xml_f="9273" txt_i="2264" txt_f="2271">; Adam </offsets><italic><offsets xml_i="9281" xml_f="9286" txt_i="2271" txt_f="2276">et al</offsets></italic><offsets xml_i="9295" xml_f="9297" txt_i="2276" txt_f="2278">. </offsets><xref rid="vms395-bib-0001" ref-type="ref"><offsets xml_i="9340" xml_f="9344" txt_i="2278" txt_f="2282">2003</offsets></xref><offsets xml_i="9351" xml_f="9542" txt_i="2282" txt_f="2469">). Furthermore, a greater antigen‐specific antibody response to equine influenza was found in mature horses supplemented with a fourfold increased amount of vitamin E (Baalsrud &amp; Overnes </offsets><xref rid="vms395-bib-0002" ref-type="ref"><offsets xml_i="9585" xml_f="9589" txt_i="2469" txt_f="2473">1986</offsets></xref><offsets xml_i="9596" xml_f="9620" txt_i="2473" txt_f="2493">). Knight &amp; Tyznik (</offsets><xref rid="vms395-bib-0010" ref-type="ref"><offsets xml_i="9663" xml_f="9667" txt_i="2493" txt_f="2497">1990</offsets></xref><offsets xml_i="9674" xml_f="9987" txt_i="2497" txt_f="2810">) observed a higher antibody response in vitamin E supplemented ponies challenged with packed sheep red blood cells intramuscularly compared to ponies supplemented with low levels of vitamin E. However, there are also reports with dietary supplements that show unaffected influenza vaccination responses (Brummer </offsets><italic><offsets xml_i="9995" xml_f="10000" txt_i="2810" txt_f="2815">et al</offsets></italic><offsets xml_i="10009" xml_f="10011" txt_i="2815" txt_f="2817">. </offsets><xref rid="vms395-bib-0003" ref-type="ref"><offsets xml_i="10054" xml_f="10058" txt_i="2817" txt_f="2821">2013</offsets></xref><offsets xml_i="10065" xml_f="10144" txt_i="2821" txt_f="2900">) or decreasing immunoglobulin concentrations in response to vaccination (Koke </offsets><italic><offsets xml_i="10152" xml_f="10157" txt_i="2900" txt_f="2905">et al</offsets></italic><offsets xml_i="10166" xml_f="10168" txt_i="2905" txt_f="2907">. </offsets><xref rid="vms395-bib-0011" ref-type="ref"><offsets xml_i="10211" xml_f="10215" txt_i="2907" txt_f="2911">2015</offsets></xref><offsets xml_i="10222" xml_f="10224" txt_i="2911" txt_f="2913">).</offsets></p><p><offsets xml_i="10231" xml_f="10242" txt_i="2914" txt_f="2925">Equi‐Strath</offsets><sup><offsets xml_i="10247" xml_f="10248" txt_i="2925" txt_f="2926">®</offsets></sup><offsets xml_i="10254" xml_f="10328" txt_i="2926" txt_f="3000"> (Bio‐Strath AG, Zürich, Switzerland) for horses is, similar as Bio‐Strath</offsets><sup><offsets xml_i="10333" xml_f="10334" txt_i="3000" txt_f="3001">®</offsets></sup><offsets xml_i="10340" xml_f="10513" txt_i="3001" txt_f="3174">, a food supplement comprised of plasmolyzed herbal yeast, malt, honey and orange juice. Several studies have shown positive effects of this supplement on the immune system </offsets><italic><offsets xml_i="10521" xml_f="10528" txt_i="3174" txt_f="3181">in vivo</offsets></italic><offsets xml_i="10537" xml_f="10542" txt_i="3181" txt_f="3186"> and </offsets><italic><offsets xml_i="10550" xml_f="10558" txt_i="3186" txt_f="3194">in vitro</offsets></italic><offsets xml_i="10567" xml_f="10576" txt_i="3194" txt_f="3203">. Leslie </offsets><italic><offsets xml_i="10584" xml_f="10589" txt_i="3203" txt_f="3208">et al</offsets></italic><offsets xml_i="10598" xml_f="10601" txt_i="3208" txt_f="3211">. (</offsets><xref rid="vms395-bib-0012" ref-type="ref"><offsets xml_i="10644" xml_f="10648" txt_i="3211" txt_f="3215">1988</offsets></xref><offsets xml_i="10655" xml_f="10657" txt_i="3215" txt_f="3217">, </offsets><xref rid="vms395-bib-0013" ref-type="ref"><offsets xml_i="10700" xml_f="10704" txt_i="3217" txt_f="3221">1989</offsets></xref><offsets xml_i="10711" xml_f="10759" txt_i="3221" txt_f="3269">) showed that daily administration of Bio‐Strath</offsets><sup><bold><offsets xml_i="10770" xml_f="10771" txt_i="3269" txt_f="3270">®</offsets></bold></sup><offsets xml_i="10784" xml_f="10848" txt_i="3270" txt_f="3334"> prolonged survival time in old mice, even after infection with </offsets><italic><offsets xml_i="10856" xml_f="10877" txt_i="3334" txt_f="3355">Staphylococcus aureus</offsets></italic><offsets xml_i="10886" xml_f="10929" txt_i="3355" txt_f="3398">. As mortality rates in mice infected with </offsets><italic><offsets xml_i="10937" xml_f="10958" txt_i="3398" txt_f="3419">Staphylococcus aureus</offsets></italic><offsets xml_i="10967" xml_f="11056" txt_i="3419" txt_f="3508"> were reduced and no changes in morbidity were observed, it was suggested that Bio‐Strath</offsets><sup><bold><offsets xml_i="11067" xml_f="11068" txt_i="3508" txt_f="3509">®</offsets></bold></sup><offsets xml_i="11081" xml_f="11121" txt_i="3509" txt_f="3549"> had a stress protectant effect (Leslie </offsets><italic><offsets xml_i="11129" xml_f="11134" txt_i="3549" txt_f="3554">et al</offsets></italic><offsets xml_i="11143" xml_f="11145" txt_i="3554" txt_f="3556">. </offsets><xref rid="vms395-bib-0012" ref-type="ref"><offsets xml_i="11188" xml_f="11192" txt_i="3556" txt_f="3560">1988</offsets></xref><offsets xml_i="11199" xml_f="11313" txt_i="3560" txt_f="3674">). In a study concerning the mode of action yielding higher survival rates, it could be determined that Bio‐Strath</offsets><sup><bold><offsets xml_i="11324" xml_f="11325" txt_i="3674" txt_f="3675">®</offsets></bold></sup><offsets xml_i="11338" xml_f="11494" txt_i="3675" txt_f="3831"> administration encourages more rapid and more efficient mobilization of leucocytes including helper T‐lymphocytes as well as B‐lymphocytes in mice (Joller </offsets><xref rid="vms395-bib-0008" ref-type="ref"><offsets xml_i="11537" xml_f="11541" txt_i="3831" txt_f="3835">1988</offsets></xref><offsets xml_i="11548" xml_f="11570" txt_i="3835" txt_f="3853">; Joller &amp; Aeppli </offsets><xref rid="vms395-bib-0009" ref-type="ref"><offsets xml_i="11613" xml_f="11617" txt_i="3853" txt_f="3857">1989</offsets></xref><offsets xml_i="11624" xml_f="11682" txt_i="3857" txt_f="3915">). Similar findings were seen in T‐lymphocytes activation </offsets><italic><offsets xml_i="11690" xml_f="11698" txt_i="3915" txt_f="3923">in vitro</offsets></italic><offsets xml_i="11707" xml_f="11946" txt_i="3923" txt_f="4162"> under the stress of low‐gravity as part of space biological investigations. The addition of the food supplement partly restored or even increased expression of activation markers on T‐lymphocytes after low‐gravity exposure (Schwarzenberg </offsets><italic><offsets xml_i="11954" xml_f="11959" txt_i="4162" txt_f="4167">et al</offsets></italic><offsets xml_i="11968" xml_f="11970" txt_i="4167" txt_f="4169">. </offsets><xref rid="vms395-bib-0016" ref-type="ref"><offsets xml_i="12013" xml_f="12017" txt_i="4169" txt_f="4173">2000</offsets></xref><offsets xml_i="12024" xml_f="12114" txt_i="4173" txt_f="4263">). At present, no scientific evidence is available illustrating the effects of Equi‐Strath</offsets><sup><bold><offsets xml_i="12125" xml_f="12126" txt_i="4263" txt_f="4264">®</offsets></bold></sup><offsets xml_i="12139" xml_f="12215" txt_i="4264" txt_f="4340"> on the horses’ health. The present study examined the effect of Equi‐Strath</offsets><sup><bold><offsets xml_i="12226" xml_f="12227" txt_i="4340" txt_f="4341">®</offsets></bold></sup><offsets xml_i="12240" xml_f="12402" txt_i="4341" txt_f="4503"> supplementation on antibody production and haematological parameters in response to a H3N8 influenza booster vaccination in healthy Franches‐Montagnes stallions.</offsets></p></sec><sec id="vms395-sec-0002"><title><offsets xml_i="12445" xml_f="12465" txt_i="4505" txt_f="4525">Material and methods</offsets></title><sec id="vms395-sec-0003"><title><offsets xml_i="12506" xml_f="12513" txt_i="4526" txt_f="4533">Animals</offsets></title><p><offsets xml_i="12524" xml_f="13249" txt_i="4534" txt_f="5259">The experiment was carried out at the Swiss National Stud in Avenches, and included 20 stallions of the Franches‐Montagnes breed. All horses used for the study were clinically healthy at the start of the experiment and had pre‐existing antibody titres. The stallions were on average 9.5 ± 4.5 years old, and had a bodyweight of 525 ± 30 kg (mean ± standard deviation). All of them were primary vaccinated and had received booster vaccinations every 6 months with the same strain as used in the current study. The stallions were kept in individual box stalls with straw or wood chip bedding and were fed hay or haylage. In addition, oats, barley, corn and pellets were fed daily. Water and a mineral salt block were available </offsets><italic><offsets xml_i="13257" xml_f="13267" txt_i="5259" txt_f="5269">ad libitum</offsets></italic><offsets xml_i="13276" xml_f="13377" txt_i="5269" txt_f="5370">. All animals were regularly exercised and were turned out daily into a paddock throughout the study.</offsets></p></sec><sec id="vms395-sec-0004"><title><offsets xml_i="13420" xml_f="13439" txt_i="5372" txt_f="5391">Experimental design</offsets></title><p><offsets xml_i="13450" xml_f="13537" txt_i="5392" txt_f="5479">The stallions were randomly divided into two groups (drawn by lot), a study group (SG, </offsets><italic><offsets xml_i="13545" xml_f="13546" txt_i="5479" txt_f="5480">n</offsets></italic><offsets xml_i="13555" xml_f="13631" txt_i="5480" txt_f="5556"> = 10; 8.6 ± 4.9 years, mean ± standard deviation) and a control group (CG, </offsets><italic><offsets xml_i="13639" xml_f="13640" txt_i="5556" txt_f="5557">n</offsets></italic><offsets xml_i="13649" xml_f="13791" txt_i="5557" txt_f="5699"> = 10; 10.5 ± 4.1 years, mean ± standard deviation). The animals of the study group each received daily a 0.06 mL/kg bodyweight of Equi‐Strath</offsets><sup><bold><offsets xml_i="13802" xml_f="13803" txt_i="5699" txt_f="5700">®</offsets></bold></sup><offsets xml_i="13816" xml_f="13817" txt_i="5700" txt_f="5701">
</offsets><bold><offsets xml_i="13823" xml_f="13824" txt_i="5701" txt_f="5702">,</offsets></bold><offsets xml_i="13831" xml_f="13940" txt_i="5702" txt_f="5811"> orally. The control group (CG) received a placebo equivalent in consistency, taste and colour as Equi‐Strath</offsets><sup><offsets xml_i="13945" xml_f="13946" txt_i="5811" txt_f="5812">®</offsets></sup><offsets xml_i="13952" xml_f="14054" txt_i="5812" txt_f="5914">, at the same quantity daily. The feeding staff were blinded to the group allocation of the stallions.</offsets></p><p><offsets xml_i="14061" xml_f="14312" txt_i="5915" txt_f="6166">The experiment lasted for 14 weeks starting in October 2013. The supplement and the placebo were given from the beginning of the study (week 0) until week 14 of the trial. This treatment was also used for a parallel study on the effects of Equi‐Strath</offsets><sup><offsets xml_i="14317" xml_f="14318" txt_i="6166" txt_f="6167">®</offsets></sup><offsets xml_i="14324" xml_f="14379" txt_i="6167" txt_f="6222"> supplementation on semen quality and quantity (Burger </offsets><italic><offsets xml_i="14387" xml_f="14392" txt_i="6222" txt_f="6227">et al</offsets></italic><offsets xml_i="14401" xml_f="14431" txt_i="6227" txt_f="6257">., manuscript in preparation).</offsets></p></sec><sec id="vms395-sec-0005"><title><offsets xml_i="14474" xml_f="14525" txt_i="6259" txt_f="6310">Vaccination, blood sampling and immunological assay</offsets></title><p><offsets xml_i="14536" xml_f="14592" txt_i="6311" txt_f="6367">After 10 weeks of daily supplementation with Equi‐Strath</offsets><sup><offsets xml_i="14597" xml_f="14598" txt_i="6367" txt_f="6368">®</offsets></sup><offsets xml_i="14604" xml_f="14745" txt_i="6368" txt_f="6509">, all horses were vaccinated against equine influenza strains A/equine/South Africa/4/03 and A/equine/Newmarket/2/93 of subtype H3N8 (Equilis</offsets><sup><offsets xml_i="14750" xml_f="14751" txt_i="6509" txt_f="6510">®</offsets></sup><offsets xml_i="14757" xml_f="15376" txt_i="6510" txt_f="7129"> Prequenza ad. us. vet., MSD Animal Health GmbH, Lucerne, Switzerland) as part of their half‐yearly routine booster vaccinations which were performed with the same vaccine for the previous 18 months The vaccine was administered by intramuscular injection in the left side of the neck. Immediately before week 10 of supplementation, which represents day 0 of the present study, and twice after vaccination (days 14 and 32 after vaccination), blood was sampled and analysed in order to determine the titres of specific antibodies. All blood samples were collected from the left jugular vein, immediately centrifuged (4000</offsets><italic><offsets xml_i="15384" xml_f="15385" txt_i="7129" txt_f="7130">g</offsets></italic><offsets xml_i="15394" xml_f="15734" txt_i="7130" txt_f="7470"> for 10 min) and the serum frozen at −20°C until analysis. Antibody titres were determined via the haemagglutination inhibition (HI) test using the European representative strain A/equine/Suffolk/89 of subtype H3N8. The HI test was performed on microtitre plates according to standard procedures (Office International des Epizootiés (OIE), </offsets><xref rid="vms395-bib-0015" ref-type="ref"><offsets xml_i="15777" xml_f="15781" txt_i="7470" txt_f="7474">1996</offsets></xref><offsets xml_i="15788" xml_f="15919" txt_i="7474" txt_f="7605">). In addition, a complete blood count was carried out (IDEXX Procyte Dx Haematology Analyser, IDEXX Diavet AG, Bäch, Switzerland).</offsets></p></sec><sec id="vms395-sec-0006"><title><offsets xml_i="15962" xml_f="15982" txt_i="7607" txt_f="7627">Statistical analysis</offsets></title><p><offsets xml_i="15993" xml_f="16295" txt_i="7628" txt_f="7927">Titre data were log2 transformed, and subsequently analysed using the mixed models procedure (SAS Inst. Inc., Cary, NC) with repeated measures. Two age classes were formed with horses &lt; 9 years being class 1, and horses ≥ 10 years being class 2. The model included the group (horses with Equi‐Strath</offsets><sup><bold><offsets xml_i="16306" xml_f="16307" txt_i="7927" txt_f="7928">®</offsets></bold></sup><offsets xml_i="16320" xml_f="16826" txt_i="7928" txt_f="8434"> vs. horses with Placebo), the sampling time‐point (day 14 and day 32 after vaccination) and their interaction, and age class as fixed effects. In addition, the titre before the vaccination (day 0) was used as covariable in the model to adjust for initial differences between the two groups. The animal was specified as a random effect to accommodate repeated measures of single individuals. The interaction effect was dropped from the model as this was not shown to be significant during initial analysis.</offsets></p><p><offsets xml_i="16833" xml_f="17201" txt_i="8435" txt_f="8803">Data on changes in titre compared to the titre measured before vaccination (Day 0) were analysed with the general linear model (GLM) procedure (SAS Inst. Inc., Cary, NC), including group and age class as fixed effects in the model. The interaction was dropped from the model as this was shown to be not significant during initial analysis. Effects were significant if </offsets><italic><offsets xml_i="17209" xml_f="17210" txt_i="8803" txt_f="8804">P</offsets></italic><offsets xml_i="17219" xml_f="17614" txt_i="8804" txt_f="9199"> ≤ 0.05. Model assumptions were checked using a graphical analysis of residuals and normality of errors and random effects were assessed based on qq‐plots. The Mann–Whitney U test was used to compare differences between the two groups (SG vs. CG) for blood count components on day 0 before the vaccination, and for the change in blood count components between day 0 and 32 after the vaccination.</offsets></p></sec></sec><sec id="vms395-sec-0007"><title><offsets xml_i="17663" xml_f="17685" txt_i="9202" txt_f="9224">Results and discussion</offsets></title><sec id="vms395-sec-0008"><title><offsets xml_i="17726" xml_f="17741" txt_i="9225" txt_f="9240">Antibody titres</offsets></title><p><offsets xml_i="17752" xml_f="17795" txt_i="9241" txt_f="9284">According to studies in mice infected with </offsets><italic><offsets xml_i="17803" xml_f="17824" txt_i="9284" txt_f="9305">Staphylococcus aureus</offsets></italic><offsets xml_i="17833" xml_f="17842" txt_i="9305" txt_f="9314"> (Joller </offsets><xref rid="vms395-bib-0008" ref-type="ref"><offsets xml_i="17885" xml_f="17889" txt_i="9314" txt_f="9318">1988</offsets></xref><offsets xml_i="17896" xml_f="17918" txt_i="9318" txt_f="9336">; Joller &amp; Aeppli </offsets><xref rid="vms395-bib-0009" ref-type="ref"><offsets xml_i="17961" xml_f="17965" txt_i="9336" txt_f="9340">1989</offsets></xref><offsets xml_i="17972" xml_f="18100" txt_i="9340" txt_f="9468">), B‐lymphocytes and T‐lymphocytes are expected to be more efficiently and more rapidly activated after administration of Strath</offsets><sup><bold><offsets xml_i="18111" xml_f="18112" txt_i="9468" txt_f="9469">®</offsets></bold></sup><offsets xml_i="18125" xml_f="18173" txt_i="9469" txt_f="9517"> products. To evaluate the effect of Equi‐Strath</offsets><sup><bold><offsets xml_i="18184" xml_f="18185" txt_i="9517" txt_f="9518">®</offsets></bold></sup><offsets xml_i="18198" xml_f="18506" txt_i="9518" txt_f="9826"> on the immune system of healthy stallions, antibody titres were measured before and after H3N8 influenza vaccination. The results of the present study showed a numerically linear increase in haemagglutination inhibition titres in both groups after vaccination. However, no statistically significant effect (</offsets><italic><offsets xml_i="18514" xml_f="18515" txt_i="9826" txt_f="9827">P</offsets></italic><offsets xml_i="18524" xml_f="18580" txt_i="9827" txt_f="9883"> = 0.66) of sampling time‐point was observed. In Gildea </offsets><italic><offsets xml_i="18588" xml_f="18593" txt_i="9883" txt_f="9888">et al</offsets></italic><offsets xml_i="18602" xml_f="18605" txt_i="9888" txt_f="9891">. (</offsets><xref rid="vms395-bib-0006" ref-type="ref"><offsets xml_i="18648" xml_f="18652" txt_i="9891" txt_f="9895">2011</offsets></xref><offsets xml_i="18659" xml_f="18907" txt_i="9895" txt_f="10143">) as well as in other publications, it was shown that the immune response after vaccination peaks at 2 to 4 weeks. With regard to the treatment, slightly higher titres in response to vaccination were observed in horses supplemented with Equi‐Strath</offsets><sup><offsets xml_i="18912" xml_f="18913" txt_i="10143" txt_f="10144">®</offsets></sup><offsets xml_i="18919" xml_f="19050" txt_i="10144" txt_f="10275"> compared to the horses receiving the placebo, although the measured antibody titres of the stallions supplemented with Equi‐Strath</offsets><sup><offsets xml_i="19055" xml_f="19056" txt_i="10275" txt_f="10276">®</offsets></sup><offsets xml_i="19062" xml_f="19163" txt_i="10276" txt_f="10377"> did not differ significantly across time from those of the stallions supplemented with the placebo (</offsets><italic><offsets xml_i="19171" xml_f="19172" txt_i="10377" txt_f="10378">P</offsets></italic><offsets xml_i="19181" xml_f="19197" txt_i="10378" txt_f="10394"> = 0.65; Figure </offsets><xref rid="vms395-fig-0001" ref-type="fig"><offsets xml_i="19240" xml_f="19241" txt_i="10394" txt_f="10395">1</offsets></xref><offsets xml_i="19248" xml_f="19393" txt_i="10395" txt_f="10540">). Likely, our influenza vaccination was not a sufficiently high and clinically relevant immune challenge to observe any effects from Equi‐Strath</offsets><sup><offsets xml_i="19398" xml_f="19399" txt_i="10540" txt_f="10541">®</offsets></sup><offsets xml_i="19405" xml_f="19483" txt_i="10541" txt_f="10619"> on the immune system, as was observed in the studies with mice infected with </offsets><italic><offsets xml_i="19491" xml_f="19512" txt_i="10619" txt_f="10640">Staphylococcus aureus</offsets></italic><offsets xml_i="19521" xml_f="19530" txt_i="10640" txt_f="10649"> (Joller </offsets><xref rid="vms395-bib-0008" ref-type="ref"><offsets xml_i="19573" xml_f="19577" txt_i="10649" txt_f="10653">1988</offsets></xref><offsets xml_i="19584" xml_f="19606" txt_i="10653" txt_f="10671">; Joller &amp; Aeppli </offsets><xref rid="vms395-bib-0009" ref-type="ref"><offsets xml_i="19649" xml_f="19653" txt_i="10671" txt_f="10675">1989</offsets></xref><offsets xml_i="19660" xml_f="19662" txt_i="10675" txt_f="10677">).</offsets></p><fig fig-type="Figure" xml:lang="en" id="vms395-fig-0001" orientation="portrait" position="float"><label><offsets xml_i="19771" xml_f="19779" txt_i="10678" txt_f="10686">Figure 1</offsets></label><caption><p><offsets xml_i="19799" xml_f="19836" txt_i="10686" txt_f="10723">Haemagglutination inhibition titres (</offsets><styled-content style="fixed-case"><offsets xml_i="19871" xml_f="19873" txt_i="10723" txt_f="10725">HI</offsets></styled-content><offsets xml_i="19890" xml_f="19945" txt_i="10725" txt_f="10780"> titres) of serum from stallions immunized with Equilis</offsets><sup><offsets xml_i="19950" xml_f="19951" txt_i="10780" txt_f="10781">®</offsets></sup><offsets xml_i="19957" xml_f="20049" txt_i="10781" txt_f="10873"> Prequenza ad. us. vet. vaccine over a 32‐day period during supplementation with Equi‐Strath</offsets><sup><offsets xml_i="20054" xml_f="20055" txt_i="10873" txt_f="10874">®</offsets></sup><offsets xml_i="20061" xml_f="20122" txt_i="10874" txt_f="10935"> or placebo. Results are means ± standard error of the mean (</offsets><styled-content style="fixed-case"><offsets xml_i="20157" xml_f="20160" txt_i="10935" txt_f="10938">SEM</offsets></styled-content><offsets xml_i="20177" xml_f="20179" txt_i="10938" txt_f="10940">).</offsets></p></caption><graphic id="nlm-graphic-3" xlink:href="VMS3-4-133-g001"></graphic></fig><p><offsets xml_i="20269" xml_f="20354" txt_i="10941" txt_f="11026">The difference between day 14 to 0 and day 32 to 0 for means of titres (Δ HI; Figure </offsets><xref rid="vms395-fig-0002" ref-type="fig"><offsets xml_i="20397" xml_f="20398" txt_i="11026" txt_f="11027">2</offsets></xref><offsets xml_i="20405" xml_f="20675" txt_i="11027" txt_f="11297">) confirms a linear increase of the antibody titres over time, however, no significant effect of treatment was observed for any of the calculated differences. The same applies to the observed differences between day 14 to 32 being without a significant treatment effect.</offsets></p><fig fig-type="Figure" xml:lang="en" id="vms395-fig-0002" orientation="portrait" position="float"><label><offsets xml_i="20784" xml_f="20792" txt_i="11298" txt_f="11306">Figure 2</offsets></label><caption><p><offsets xml_i="20812" xml_f="20863" txt_i="11306" txt_f="11357">Change in the haemagglutination inhibition titres (</offsets><styled-content style="fixed-case"><offsets xml_i="20898" xml_f="20900" txt_i="11357" txt_f="11359">HI</offsets></styled-content><offsets xml_i="20917" xml_f="20978" txt_i="11359" txt_f="11420"> titres, log2) of serum from stallions immunized with Equilis</offsets><sup><offsets xml_i="20983" xml_f="20984" txt_i="11420" txt_f="11421">®</offsets></sup><offsets xml_i="20990" xml_f="21082" txt_i="11421" txt_f="11513"> Prequenza ad. us. vet. vaccine over a 32‐day period during supplementation with Equi‐Strath</offsets><sup><offsets xml_i="21087" xml_f="21088" txt_i="11513" txt_f="11514">®</offsets></sup><offsets xml_i="21094" xml_f="21106" txt_i="11514" txt_f="11526"> or placebo.</offsets></p></caption><graphic id="nlm-graphic-5" xlink:href="VMS3-4-133-g002"></graphic></fig><p><offsets xml_i="21196" xml_f="21325" txt_i="11527" txt_f="11656">Furthermore, we found an age class effect with younger horses having more markedly increased HI titres compared to older horses (</offsets><italic><offsets xml_i="21333" xml_f="21334" txt_i="11656" txt_f="11657">P</offsets></italic><offsets xml_i="21343" xml_f="21415" txt_i="11657" txt_f="11729"> = 0.02) during the first 14 days after vaccination. Similarly Muirhead </offsets><italic><offsets xml_i="21423" xml_f="21428" txt_i="11729" txt_f="11734">et al</offsets></italic><offsets xml_i="21437" xml_f="21440" txt_i="11734" txt_f="11737">. (</offsets><xref rid="vms395-bib-0014" ref-type="ref"><offsets xml_i="21483" xml_f="21487" txt_i="11737" txt_f="11741">2010</offsets></xref><offsets xml_i="21494" xml_f="21782" txt_i="11741" txt_f="12025">), showed age was a factor affecting the immune response, with aged horses having a significantly reduced response to influenza vaccination compared to the younger adult horses, likely because they had higher pre‐vaccination higher antibody titres. In their review, Solana &amp; Pawelec (</offsets><xref rid="vms395-bib-0017" ref-type="ref"><offsets xml_i="21825" xml_f="21829" txt_i="12025" txt_f="12029">1998</offsets></xref><offsets xml_i="21836" xml_f="22039" txt_i="12029" txt_f="12232">) question the use of booster vaccination in older horses as this may lead to a state of unresponsiveness due to ‘clonal exhaustion’ of the antigen‐specific lymphocytes. In the current study, Equi‐Strath</offsets><sup><offsets xml_i="22044" xml_f="22045" txt_i="12232" txt_f="12233">®</offsets></sup><offsets xml_i="22051" xml_f="22138" txt_i="12233" txt_f="12320"> supplementation did not modulate the immune response in stallions with respect to age.</offsets></p></sec><sec id="vms395-sec-0009"><title><offsets xml_i="22181" xml_f="22201" txt_i="12322" txt_f="12342">Complete blood count</offsets></title><p><offsets xml_i="22212" xml_f="22533" txt_i="12343" txt_f="12664">The blood count did not show any significant difference between the study group and the control group over time from day 0 until day 32. Interestingly, at the day of vaccination, after 14 weeks of supplementation, significant differences between the groups in the WBC count, neutrophils, monocytes and eosinophils (Table </offsets><xref rid="vms395-tbl-0001" ref-type="table-wrap"><offsets xml_i="22583" xml_f="22584" txt_i="12664" txt_f="12665">1</offsets></xref><offsets xml_i="22591" xml_f="22689" txt_i="12665" txt_f="12763">) were found. The total WBC count was increased in the control group compared to the study group (</offsets><italic><offsets xml_i="22697" xml_f="22698" txt_i="12763" txt_f="12764">P</offsets></italic><offsets xml_i="22707" xml_f="22735" txt_i="12764" txt_f="12792"> = 0.01). Also neutrophils (</offsets><italic><offsets xml_i="22743" xml_f="22744" txt_i="12792" txt_f="12793">P</offsets></italic><offsets xml_i="22753" xml_f="22774" txt_i="12793" txt_f="12814"> = 0.02), monocytes (</offsets><italic><offsets xml_i="22782" xml_f="22783" txt_i="12814" txt_f="12815">P</offsets></italic><offsets xml_i="22792" xml_f="22818" txt_i="12815" txt_f="12841"> = 0.03) and eosinophils (</offsets><italic><offsets xml_i="22826" xml_f="22827" txt_i="12841" txt_f="12842">P</offsets></italic><offsets xml_i="22836" xml_f="23154" txt_i="12842" txt_f="13160"> = 0.01) were increased in the placebo control group compared to the study group. Even though, the observed differences were statistically significant, these small effects are not likely to be clinically relevant. As no blood samples for blood count were taken before the beginning of the administration of Equi‐Strath</offsets><sup><offsets xml_i="23159" xml_f="23160" txt_i="13160" txt_f="13161">®</offsets></sup><offsets xml_i="23166" xml_f="23240" txt_i="13161" txt_f="13235"> no comparison before and after the 14 week supplementation could be made.</offsets></p><table-wrap id="vms395-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label><offsets xml_i="23338" xml_f="23345" txt_i="13236" txt_f="13243">Table 1</offsets></label><caption><p><offsets xml_i="23365" xml_f="23432" txt_i="13243" txt_f="13310">Blood count (mean ± SEM) in stallions supplemented with Equi‐Strath</offsets><sup><offsets xml_i="23437" xml_f="23438" txt_i="13310" txt_f="13311">®</offsets></sup><offsets xml_i="23444" xml_f="23455" txt_i="13311" txt_f="13322"> or placebo</offsets></p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"></col><col style="border-right:solid 1px #000000" span="1"></col><col style="border-right:solid 1px #000000" span="1"></col><col style="border-right:solid 1px #000000" span="1"></col><col style="border-right:solid 1px #000000" span="1"></col><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="top" colspan="1"><offsets xml_i="23919" xml_f="23928" txt_i="13323" txt_f="13332">Parameter</offsets></th><th align="left" rowspan="2" valign="top" colspan="1"><offsets xml_i="23987" xml_f="24015" txt_i="13332" txt_f="13360">Days relative to vaccination</offsets></th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1"><offsets xml_i="24114" xml_f="24132" txt_i="13360" txt_f="13378">Experimental group</offsets></th><th align="left" rowspan="2" valign="top" colspan="1"><offsets xml_i="24191" xml_f="24192" txt_i="13378" txt_f="13379">
</offsets><italic><offsets xml_i="24200" xml_f="24201" txt_i="13379" txt_f="13380">P</offsets></italic><offsets xml_i="24210" xml_f="24229" txt_i="13380" txt_f="13399">‐value Mann–Whitney</offsets></th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1"><offsets xml_i="24337" xml_f="24348" txt_i="13399" txt_f="13410">Equi‐Strath</offsets><sup><offsets xml_i="24353" xml_f="24354" txt_i="13410" txt_f="13411">®</offsets></sup><offsets xml_i="24360" xml_f="24361" txt_i="13411" txt_f="13412">
</offsets></th><th align="left" valign="top" rowspan="1" colspan="1"><offsets xml_i="24420" xml_f="24427" txt_i="13412" txt_f="13419">Placebo</offsets></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="24497" xml_f="24505" txt_i="13419" txt_f="13427">RBC (x10</offsets><sup><offsets xml_i="24510" xml_f="24512" txt_i="13427" txt_f="13429">12</offsets></sup><offsets xml_i="24518" xml_f="24521" txt_i="13429" txt_f="13432">/L)</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="24567" xml_f="24568" txt_i="13433" txt_f="13434">0</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="24623" xml_f="24635" txt_i="13435" txt_f="13447">7.29 ± 0.108</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="24690" xml_f="24702" txt_i="13448" txt_f="13460">7.36 ± 0.115</offsets></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="24757" xml_f="24761" txt_i="13461" txt_f="13465">0.48</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="24816" xml_f="24831" txt_i="13466" txt_f="13481">Red blood cells</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="24877" xml_f="24889" txt_i="13482" txt_f="13494">Changed 0–32</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="24944" xml_f="24956" txt_i="13495" txt_f="13507">−0.10 ± 0.16</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="25011" xml_f="25023" txt_i="13508" txt_f="13520">−0.06 ± 0.07</offsets></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="25078" xml_f="25082" txt_i="13521" txt_f="13525">0.58</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="25137" xml_f="25144" txt_i="13526" txt_f="13533">PCV (%)</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="25190" xml_f="25191" txt_i="13534" txt_f="13535">0</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="25246" xml_f="25259" txt_i="13536" txt_f="13549">32.66 ± 0.551</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="25314" xml_f="25327" txt_i="13550" txt_f="13563">33.07 ± 0.518</offsets></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="25382" xml_f="25386" txt_i="13564" txt_f="13568">0.41</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="25441" xml_f="25459" txt_i="13569" txt_f="13587">Packed cell volume</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="25505" xml_f="25517" txt_i="13588" txt_f="13600">Changed 0–32</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="25572" xml_f="25584" txt_i="13601" txt_f="13613">−0.08 ± 0.76</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="25639" xml_f="25650" txt_i="13614" txt_f="13625">0.14 ± 0.34</offsets></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="25705" xml_f="25709" txt_i="13626" txt_f="13630">0.74</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="25764" xml_f="25774" txt_i="13631" txt_f="13641">HGB (g/dL)</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="25820" xml_f="25821" txt_i="13642" txt_f="13643">0</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="25876" xml_f="25889" txt_i="13644" txt_f="13657">11.93 ± 0.156</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="25944" xml_f="25957" txt_i="13658" txt_f="13671">12.06 ± 0.153</offsets></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="26012" xml_f="26016" txt_i="13672" txt_f="13676">0.40</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="26071" xml_f="26082" txt_i="13677" txt_f="13688">Haemoglobin</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="26128" xml_f="26140" txt_i="13689" txt_f="13701">Changed 0–32</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="26195" xml_f="26207" txt_i="13702" txt_f="13714">−0.15 ± 0.23</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="26262" xml_f="26274" txt_i="13715" txt_f="13727">−0.04 ± 0.09</offsets></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="26329" xml_f="26333" txt_i="13728" txt_f="13732">0.55</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="26388" xml_f="26397" txt_i="13733" txt_f="13742">WBC (x 10</offsets><sup><offsets xml_i="26402" xml_f="26403" txt_i="13742" txt_f="13743">9</offsets></sup><offsets xml_i="26409" xml_f="26412" txt_i="13743" txt_f="13746">/L)</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="26458" xml_f="26459" txt_i="13747" txt_f="13748">0</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="26514" xml_f="26526" txt_i="13749" txt_f="13761">5.47 ± 0.277</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="26581" xml_f="26593" txt_i="13762" txt_f="13774">6.56 ± 0.225</offsets></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="26648" xml_f="26652" txt_i="13775" txt_f="13779">0.01</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="26707" xml_f="26724" txt_i="13780" txt_f="13797">White blood cells</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="26770" xml_f="26782" txt_i="13798" txt_f="13810">Changed 0–32</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="26837" xml_f="26849" txt_i="13811" txt_f="13823">−0.20 ± 0.43</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="26904" xml_f="26916" txt_i="13824" txt_f="13836">−0.33 ± 0.17</offsets></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="26971" xml_f="26975" txt_i="13837" txt_f="13841">0.23</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="27030" xml_f="27038" txt_i="13842" txt_f="13850">NEU (x10</offsets><sup><offsets xml_i="27043" xml_f="27044" txt_i="13850" txt_f="13851">9</offsets></sup><offsets xml_i="27050" xml_f="27053" txt_i="13851" txt_f="13854">/L)</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="27099" xml_f="27100" txt_i="13855" txt_f="13856">0</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="27155" xml_f="27167" txt_i="13857" txt_f="13869">3.05 ± 0.199</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="27222" xml_f="27234" txt_i="13870" txt_f="13882">3.73 ± 0.172</offsets></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="27289" xml_f="27293" txt_i="13883" txt_f="13887">0.02</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="27348" xml_f="27359" txt_i="13888" txt_f="13899">Neutrophils</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="27405" xml_f="27417" txt_i="13900" txt_f="13912">Changed 0–32</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="27472" xml_f="27483" txt_i="13913" txt_f="13924">0.02 ± 0.27</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="27538" xml_f="27550" txt_i="13925" txt_f="13937">−0.06 ± 0.12</offsets></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="27605" xml_f="27609" txt_i="13938" txt_f="13942">0.63</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="27664" xml_f="27672" txt_i="13943" txt_f="13951">LYM (x10</offsets><sup><offsets xml_i="27677" xml_f="27678" txt_i="13951" txt_f="13952">9</offsets></sup><offsets xml_i="27684" xml_f="27687" txt_i="13952" txt_f="13955">/L)</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="27733" xml_f="27734" txt_i="13956" txt_f="13957">0</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="27789" xml_f="27801" txt_i="13958" txt_f="13970">2.01 ± 0.090</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="27856" xml_f="27868" txt_i="13971" txt_f="13983">2.25 ± 0.088</offsets></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="27923" xml_f="27927" txt_i="13984" txt_f="13988">0.10</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="27982" xml_f="27993" txt_i="13989" txt_f="14000">Lymphocytes</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="28039" xml_f="28051" txt_i="14001" txt_f="14013">Changed 0–32</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="28106" xml_f="28118" txt_i="14014" txt_f="14026">−0.19 ± 0.15</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="28173" xml_f="28185" txt_i="14027" txt_f="14039">−0.26 ± 0.08</offsets></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="28240" xml_f="28244" txt_i="14040" txt_f="14044">0.35</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="28299" xml_f="28308" txt_i="14045" txt_f="14054">MONO (x10</offsets><sup><offsets xml_i="28313" xml_f="28314" txt_i="14054" txt_f="14055">9</offsets></sup><offsets xml_i="28320" xml_f="28323" txt_i="14055" txt_f="14058">/L)</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="28369" xml_f="28370" txt_i="14059" txt_f="14060">0</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="28425" xml_f="28437" txt_i="14061" txt_f="14073">0.27 ± 0.019</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="28492" xml_f="28504" txt_i="14074" txt_f="14086">0.32 ± 0.015</offsets></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="28559" xml_f="28563" txt_i="14087" txt_f="14091">0.03</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="28618" xml_f="28627" txt_i="14092" txt_f="14101">Monocytes</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="28673" xml_f="28685" txt_i="14102" txt_f="14114">Changed 0–32</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="28740" xml_f="28752" txt_i="14115" txt_f="14127">−0.01 ± 0.03</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="28807" xml_f="28818" txt_i="14128" txt_f="14139">0.00 ± 0.02</offsets></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="28873" xml_f="28877" txt_i="14140" txt_f="14144">0.52</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="28932" xml_f="28940" txt_i="14145" txt_f="14153">EOS (x10</offsets><sup><offsets xml_i="28945" xml_f="28946" txt_i="14153" txt_f="14154">9</offsets></sup><offsets xml_i="28952" xml_f="28955" txt_i="14154" txt_f="14157">/L)</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="29001" xml_f="29002" txt_i="14158" txt_f="14159">0</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="29057" xml_f="29069" txt_i="14160" txt_f="14172">0.12 ± 0.020</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="29124" xml_f="29136" txt_i="14173" txt_f="14185">0.25 ± 0.047</offsets></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="29191" xml_f="29195" txt_i="14186" txt_f="14190">0.01</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="29250" xml_f="29261" txt_i="14191" txt_f="14202">Eosinophils</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="29307" xml_f="29319" txt_i="14203" txt_f="14215">Changed 0–32</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="29374" xml_f="29386" txt_i="14216" txt_f="14228">−0.01 ± 0.01</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="29441" xml_f="29453" txt_i="14229" txt_f="14241">−0.02 ± 0.04</offsets></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="29508" xml_f="29512" txt_i="14242" txt_f="14246">0.97</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="29567" xml_f="29576" txt_i="14247" txt_f="14256">BASO (x10</offsets><sup><offsets xml_i="29581" xml_f="29582" txt_i="14256" txt_f="14257">9</offsets></sup><offsets xml_i="29588" xml_f="29591" txt_i="14257" txt_f="14260">/L)</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="29637" xml_f="29638" txt_i="14261" txt_f="14262">0</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="29693" xml_f="29706" txt_i="14263" txt_f="14276">0.019 ± 0.005</offsets></td><td align="char" char="±" rowspan="1" colspan="1"></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="29816" xml_f="29820" txt_i="14278" txt_f="14282">0.70</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="29875" xml_f="29884" txt_i="14283" txt_f="14292">Basophils</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="29930" xml_f="29942" txt_i="14293" txt_f="14305">Changed 0–32</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="29997" xml_f="30009" txt_i="14306" txt_f="14318">−0.00 ± 0.00</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="30064" xml_f="30075" txt_i="14319" txt_f="14330">0.01 ± 0.01</offsets></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="30130" xml_f="30134" txt_i="14331" txt_f="14335">0.11</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="30189" xml_f="30196" txt_i="14336" txt_f="14343">PTL (K/</offsets><italic><offsets xml_i="30204" xml_f="30205" txt_i="14343" txt_f="14344">μ</offsets></italic><offsets xml_i="30214" xml_f="30216" txt_i="14344" txt_f="14346">L)</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="30262" xml_f="30263" txt_i="14347" txt_f="14348">0</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="30318" xml_f="30331" txt_i="14349" txt_f="14362">105.7 ± 11.09</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="30386" xml_f="30398" txt_i="14363" txt_f="14375">124.1 ± 7.01</offsets></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="30453" xml_f="30457" txt_i="14376" txt_f="14380">0.33</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><offsets xml_i="30512" xml_f="30526" txt_i="14381" txt_f="14395">Platelet count</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="30572" xml_f="30584" txt_i="14396" txt_f="14408">Changed 0–32</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="30639" xml_f="30650" txt_i="14409" txt_f="14420">3.70 ± 9.89</offsets></td><td align="char" char="±" rowspan="1" colspan="1"><offsets xml_i="30705" xml_f="30718" txt_i="14421" txt_f="14434">−0.40 ± 11.20</offsets></td><td align="char" char="." rowspan="1" colspan="1"><offsets xml_i="30773" xml_f="30777" txt_i="14435" txt_f="14439">0.85</offsets></td></tr></tbody></table><permissions><copyright-holder><offsets xml_i="30834" xml_f="30860" txt_i="14440" txt_f="14462">John Wiley &amp; Sons, Ltd</offsets></copyright-holder></permissions></table-wrap></sec></sec><sec id="vms395-sec-0010"><title><offsets xml_i="30951" xml_f="30961" txt_i="14464" txt_f="14474">Conclusion</offsets></title><p><offsets xml_i="30972" xml_f="30989" txt_i="14475" txt_f="14492">Daily Equi‐Strath</offsets><sup><offsets xml_i="30994" xml_f="30995" txt_i="14492" txt_f="14493">®</offsets></sup><offsets xml_i="31001" xml_f="31165" txt_i="14493" txt_f="14657"> supplementation did not affect the adaptive immune response in stallions after a routine H3N8 influenza vaccination. An effect of clinical relevance of Equi‐Strath</offsets><sup><offsets xml_i="31170" xml_f="31171" txt_i="14657" txt_f="14658">®</offsets></sup><offsets xml_i="31177" xml_f="31377" txt_i="14658" txt_f="14858"> on the immune system in horses was not demonstrated through the immunological stimulation by booster vaccination in horses with pre‐existing immunity. It remains to be elucidated, whether Equi‐Strath</offsets><sup><offsets xml_i="31382" xml_f="31383" txt_i="14858" txt_f="14859">®</offsets></sup><offsets xml_i="31389" xml_f="31554" txt_i="14859" txt_f="15024"> supplementation may induce a protective effect in horses exposed to a stronger immune challenge or in immunologically naïve horses without any previous vaccination.</offsets></p></sec><sec id="vms395-sec-0012"><title><offsets xml_i="31597" xml_f="31614" txt_i="15026" txt_f="15043">Source of funding</offsets></title><p><offsets xml_i="31625" xml_f="31652" txt_i="15044" txt_f="15071">This work was supported by </offsets><italic><offsets xml_i="31660" xml_f="31740" txt_i="15071" txt_f="15151">ISMEquine Research, the School of Agricultural, Forest and Food Sciences (HAFL),</offsets></italic><offsets xml_i="31749" xml_f="31767" txt_i="15151" txt_f="15169"> and by Bio‐Strath</offsets><sup><bold><offsets xml_i="31778" xml_f="31779" txt_i="15169" txt_f="15170">®</offsets></bold></sup><offsets xml_i="31792" xml_f="31793" txt_i="15170" txt_f="15171">.</offsets></p></sec><sec id="vms395-sec-0013"><title><offsets xml_i="31836" xml_f="31856" txt_i="15173" txt_f="15193">Conflict of interest</offsets></title><p><offsets xml_i="31867" xml_f="32013" txt_i="15194" txt_f="15340">None of the authors has a financial or personal relationship with people or organizations that could inappropriately influence or bias this study.</offsets></p></sec><sec id="vms395-sec-0014"><title><offsets xml_i="32056" xml_f="32073" txt_i="15342" txt_f="15359">Ethical statement</offsets></title><p><offsets xml_i="32084" xml_f="32246" txt_i="15360" txt_f="15522">The experiment followed the Swiss Law on Animal Protection and was authorized by the Committee of Animal Experiments of the Canton Vaud, Switzerland (no. 2667.1).</offsets></p></sec><sec id="vms395-sec-0015"><title><offsets xml_i="32289" xml_f="32302" txt_i="15524" txt_f="15537">Contributions</offsets></title><p><offsets xml_i="32313" xml_f="32553" txt_i="15538" txt_f="15778">H.v.D, R.Z., V.G. and D.B. designed the study, D.B. supervised the experiments that were performed by R.Z., E.J. and D.W., H.v.D. analyzed the data. H.v.D., D.W. and D.B. wrote the manuscript that was then critically revised by all authors.</offsets></p></sec><sec id="vms395-sec-0016"><title><offsets xml_i="32596" xml_f="32626" txt_i="15780" txt_f="15810">Data access and responsibility</offsets></title><p><offsets xml_i="32637" xml_f="32851" txt_i="15811" txt_f="16025">The principal investigators, Hendrika van Dorland and Dominik Burger, had full access to all of the data in the study and take the responsibility for the integrity of the data and the accuracy of the data analysis.</offsets></p></sec><sec sec-type="supplementary-material"><title><offsets xml_i="32907" xml_f="32929" txt_i="16027" txt_f="16049">Supporting information</offsets></title><supplementary-material content-type="local-data" id="vms395-sup-0001"><caption><p><offsets xml_i="33020" xml_f="33021" txt_i="16050" txt_f="16051">
</offsets><bold><offsets xml_i="33027" xml_f="33036" txt_i="16051" txt_f="16060">Table S1.</offsets></bold><offsets xml_i="33043" xml_f="33128" txt_i="16060" txt_f="16145"> CONSORT 2010 checklist of information to include when reporting a randomized trial*.</offsets></p></caption><media xlink:href="VMS3-4-133-s001.doc"><caption><p><offsets xml_i="33194" xml_f="33230" txt_i="16146" txt_f="16182">Click here for additional data file.</offsets></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="vms395-sup-0002"><caption><p><offsets xml_i="33360" xml_f="33361" txt_i="16183" txt_f="16184">
</offsets><bold><offsets xml_i="33367" xml_f="33377" txt_i="16184" txt_f="16194">Figure S1.</offsets></bold><offsets xml_i="33384" xml_f="33411" txt_i="16194" txt_f="16221"> CONSORT 2010 Flow Diagram.</offsets></p></caption><media xlink:href="VMS3-4-133-s002.doc"><caption><p><offsets xml_i="33477" xml_f="33513" txt_i="16222" txt_f="16258">Click here for additional data file.</offsets></p></caption></media></supplementary-material></sec></body><back><ack id="vms395-sec-0011"><title>Acknowledgements</title><p>We thank the Swiss National Stud for providing infrastructures and animals, and we gratefully appreciate the assistance of the vet team of ISME, Selina Thomas and Peter Joller.</p></ack><ref-list content-type="cited-references" id="vms395-bibl-0001"><title>References</title><ref id="vms395-bib-0001"><mixed-citation publication-type="journal" id="vms395-cit-0001">
<string-name>
<surname>Adam</surname>
<given-names>O.</given-names>
</string-name>, <string-name>
<surname>Beringer</surname>
<given-names>C.</given-names>
</string-name>, <string-name>
<surname>Kless</surname>
<given-names>T.</given-names>
</string-name>, <string-name>
<surname>Lemmen</surname>
<given-names>C.</given-names>
</string-name>, <string-name>
<surname>Adam</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Wiseman</surname>
<given-names>M.</given-names>
</string-name>
<italic>et al</italic> (<year>2003</year>) <article-title>Anti‐inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis</article-title>. <source xml:lang="en">Rheumatology International</source>
<volume>23</volume>, <fpage>27</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="pmid">12548439</pub-id></mixed-citation></ref><ref id="vms395-bib-0002"><mixed-citation publication-type="journal" id="vms395-cit-0002">
<string-name>
<surname>Baalsrud</surname>
<given-names>K.J.</given-names>
</string-name> &amp; <string-name>
<surname>Overnes</surname>
<given-names>G.</given-names>
</string-name> (<year>1986</year>) <article-title>Influence of vitamin E and selenium supplement on antibody production in horses</article-title>. <source xml:lang="en">Equine Veterinary Journal</source>
<volume>18</volume>, <fpage>472</fpage>–<lpage>474</lpage>.<pub-id pub-id-type="pmid">3803361</pub-id></mixed-citation></ref><ref id="vms395-bib-0003"><mixed-citation publication-type="journal" id="vms395-cit-0003">
<string-name>
<surname>Brummer</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Hayes</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Adams</surname>
<given-names>A.A.</given-names>
</string-name>, <string-name>
<surname>Horohov</surname>
<given-names>D.W.</given-names>
</string-name>, <string-name>
<surname>Dawson</surname>
<given-names>K.A.</given-names>
</string-name> &amp; <string-name>
<surname>Lawrence</surname>
<given-names>L.M.</given-names>
</string-name> (<year>2013</year>) <article-title>The effect of selenium supplementation on vaccination response and immune function in adult horses</article-title>. <source xml:lang="en">Journal of Animal Science</source>
<volume>91</volume>, <fpage>3702</fpage>–<lpage>3715</lpage>.<pub-id pub-id-type="pmid">23658361</pub-id></mixed-citation></ref><ref id="vms395-bib-0004"><mixed-citation publication-type="journal" id="vms395-cit-0004">
<string-name>
<surname>Curtis</surname>
<given-names>C.L.</given-names>
</string-name>, <string-name>
<surname>Hughes</surname>
<given-names>C.E.</given-names>
</string-name>, <string-name>
<surname>Flanner</surname>
<given-names>C.R.</given-names>
</string-name>, <string-name>
<surname>Little</surname>
<given-names>C.B.</given-names>
</string-name>, <string-name>
<surname>Harwood</surname>
<given-names>J.L.</given-names>
</string-name> &amp; <string-name>
<surname>Caterson</surname>
<given-names>B.</given-names>
</string-name> (<year>2000</year>) <article-title>N‐3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation</article-title>. <source xml:lang="en">Journal of Biological Chemistry</source>
<volume>275</volume>, <fpage>721</fpage>–<lpage>724</lpage>.<pub-id pub-id-type="pmid">10625599</pub-id></mixed-citation></ref><ref id="vms395-bib-0005"><mixed-citation publication-type="journal" id="vms395-cit-0005">
<string-name>
<surname>Folsom</surname>
<given-names>R.W.</given-names>
</string-name>, <string-name>
<surname>Littlefield‐Chabaud</surname>
<given-names>M.A.</given-names>
</string-name>, <string-name>
<surname>French</surname>
<given-names>D.D.</given-names>
</string-name>, <string-name>
<surname>Pourciau</surname>
<given-names>S.S.</given-names>
</string-name>, <string-name>
<surname>Mistric</surname>
<given-names>L.</given-names>
</string-name> &amp; <string-name>
<surname>Horohov</surname>
<given-names>D.W.</given-names>
</string-name> (<year>2001</year>) <article-title>Exercise alters the immune response to equine influenza virus and increases susceptibility to infection</article-title>. <source xml:lang="en">Equine Veterinary Journal</source>
<volume>33</volume>, <fpage>664</fpage>–<lpage>669</lpage>.<pub-id pub-id-type="pmid">11770987</pub-id></mixed-citation></ref><ref id="vms395-bib-0006"><mixed-citation publication-type="journal" id="vms395-cit-0006">
<string-name>
<surname>Gildea</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Arkins</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Walsh</surname>
<given-names>C.</given-names>
</string-name> &amp; <string-name>
<surname>Cullinane</surname>
<given-names>A.</given-names>
</string-name> (<year>2011</year>) <article-title>A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt Horses – a randomized blind study</article-title>. <source xml:lang="en">Vaccine</source>
<volume>29</volume>, <fpage>3917</fpage>–<lpage>3922</lpage>.<pub-id pub-id-type="pmid">21419776</pub-id></mixed-citation></ref><ref id="vms395-bib-0007"><mixed-citation publication-type="journal" id="vms395-cit-0007">
<string-name>
<surname>Horohov</surname>
<given-names>D.W.</given-names>
</string-name>, <string-name>
<surname>Dimock</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Guirnalda</surname>
<given-names>P.</given-names>
</string-name>, <string-name>
<surname>Folsom</surname>
<given-names>R.W.</given-names>
</string-name>, <string-name>
<surname>McKeever</surname>
<given-names>K.H.</given-names>
</string-name> &amp; <string-name>
<surname>Malinowski</surname>
<given-names>K.</given-names>
</string-name> (<year>1999</year>) <article-title>Effect of exercise on the immune response of young and old horses</article-title>. <source xml:lang="en">American Journal of Veterinary Research</source>
<volume>60</volume>, <fpage>643</fpage>–<lpage>664</lpage>.<pub-id pub-id-type="pmid">10328438</pub-id></mixed-citation></ref><ref id="vms395-bib-0008"><mixed-citation publication-type="journal" id="vms395-cit-0008">
<string-name>
<surname>Joller</surname>
<given-names>P.</given-names>
</string-name> (<year>1988</year>) <article-title>Reinforcing immune defence against bacterial infections using a yeast preparation</article-title>. <source xml:lang="en">SWISS MED</source>
<volume>10</volume>, <fpage>30</fpage>–<lpage>35</lpage>.</mixed-citation></ref><ref id="vms395-bib-0009"><mixed-citation publication-type="journal" id="vms395-cit-0009">
<string-name>
<surname>Joller</surname>
<given-names>P.</given-names>
</string-name> &amp; <string-name>
<surname>Aeppli</surname>
<given-names>R.E.</given-names>
</string-name> (<year>1989</year>) <article-title>Influence of prophylactic administration of a yeast preparation (Bio‐Strath<sup>®</sup>) on the defence response</article-title>. <source xml:lang="en">SWISS MED</source>
<volume>11</volume>, <fpage>66</fpage>–<lpage>71</lpage>.</mixed-citation></ref><ref id="vms395-bib-0010"><mixed-citation publication-type="journal" id="vms395-cit-0010">
<string-name>
<surname>Knight</surname>
<given-names>D.A.</given-names>
</string-name> &amp; <string-name>
<surname>Tyznik</surname>
<given-names>W.J.</given-names>
</string-name> (<year>1990</year>) <article-title>The effect of dietary selenium on humoral immunocompetence of ponies</article-title>. <source xml:lang="en">Journal of Animal Science</source>
<volume>68</volume>, <fpage>1311</fpage>–<lpage>1317</lpage>.<pub-id pub-id-type="pmid">2365642</pub-id></mixed-citation></ref><ref id="vms395-bib-0011"><mixed-citation publication-type="journal" id="vms395-cit-0011">
<string-name>
<surname>Koke</surname>
<given-names>K.</given-names>
</string-name>, <string-name>
<surname>Reddish</surname>
<given-names>J.M.</given-names>
</string-name> &amp; <string-name>
<surname>Cole</surname>
<given-names>K.</given-names>
</string-name> (<year>2015</year>) <article-title>Influence of dietary yeast supplementation on immunoglobulin concentrations in response to vaccination in Quarter Horse mares</article-title>. <source xml:lang="en">Journal of Equine Veterinary Science</source>
<volume>35</volume>, <fpage>430</fpage>.</mixed-citation></ref><ref id="vms395-bib-0012"><mixed-citation publication-type="journal" id="vms395-cit-0012">
<string-name>
<surname>Leslie</surname>
<given-names>G.B.</given-names>
</string-name>, <string-name>
<surname>Frasdillla</surname>
<given-names>J.C.</given-names>
</string-name>, <string-name>
<surname>Salmon</surname>
<given-names>G.K.</given-names>
</string-name> &amp; <string-name>
<surname>Sturman</surname>
<given-names>G.</given-names>
</string-name> (<year>1988</year>) <article-title>The Effect of lifetime treatment with a herbal yeast food supplement (Bio‐Strath<sup>®</sup>) on survival and infection resistance in mice</article-title>. <source xml:lang="en">SWISS MED</source>
<volume>10</volume>, <fpage>36</fpage>–<lpage>38</lpage>.</mixed-citation></ref><ref id="vms395-bib-0013"><mixed-citation publication-type="journal" id="vms395-cit-0013">
<string-name>
<surname>Leslie</surname>
<given-names>G.B.</given-names>
</string-name>, <string-name>
<surname>Canham</surname>
<given-names>D.</given-names>
</string-name> &amp; <string-name>
<surname>Frasdilla</surname>
<given-names>J.C.</given-names>
</string-name> (<year>1989</year>) <article-title>The effect of 30 days treatment with a herbal yeast food supplement (Bio‐Strath<sup>®</sup>) on infection resistance in old mice</article-title>. <source xml:lang="en">SWISS MED</source>
<volume>11</volume>, <fpage>30</fpage>–<lpage>31</lpage>.</mixed-citation></ref><ref id="vms395-bib-0014"><mixed-citation publication-type="journal" id="vms395-cit-0014">
<string-name>
<surname>Muirhead</surname>
<given-names>T.L.</given-names>
</string-name>, <string-name>
<surname>McClure</surname>
<given-names>J.T.</given-names>
</string-name>, <string-name>
<surname>Wichtel</surname>
<given-names>J.J.</given-names>
</string-name>, <string-name>
<surname>Stryhn</surname>
<given-names>H.</given-names>
</string-name>, <string-name>
<surname>Markham</surname>
<given-names>R.J.F.</given-names>
</string-name>, <string-name>
<surname>McFarlane</surname>
<given-names>D.</given-names>
</string-name> &amp; <string-name>
<surname>Lunn</surname>
<given-names>D.P.</given-names>
</string-name> (<year>2010</year>) <article-title>The effect of age on the immune response of horses to vaccination</article-title>. <source xml:lang="en">Journal of Comparative Pathology</source>
<volume>142</volume>, <fpage>S85</fpage>–<lpage>S90</lpage>.<pub-id pub-id-type="pmid">19954792</pub-id></mixed-citation></ref><ref id="vms395-bib-0015"><mixed-citation publication-type="book" id="vms395-cit-0015">
<collab collab-type="authors">Office International des Epizootiés (OIE)</collab>
(<year>1996</year>) <chapter-title>Equine Influenza</chapter-title>
<source xml:lang="en">Manual of Standards for Diagnostic Tests and Vaccines</source>. <edition>3rd edn</edition>, <fpage>409</fpage>–<lpage>419</lpage>. <publisher-name>Office International Des Epizooties</publisher-name>
<publisher-loc>Paris</publisher-loc>.</mixed-citation></ref><ref id="vms395-bib-0016"><mixed-citation publication-type="journal" id="vms395-cit-0016">
<string-name>
<surname>Schwarzenberg</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Joller</surname>
<given-names>P.</given-names>
</string-name> &amp; <string-name>
<surname>Cogoli</surname>
<given-names>A.</given-names>
</string-name> (<year>2000</year>) <article-title>Stress‐compensation by a food supplement based on yeast plasmolysate in mitogen activated T‐lymphocytes under simulated low‐gravity</article-title>. <source xml:lang="en">Biological Sciences in Space</source>
<volume>14</volume>, <fpage>3</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">11543151</pub-id></mixed-citation></ref><ref id="vms395-bib-0017"><mixed-citation publication-type="journal" id="vms395-cit-0017">
<string-name>
<surname>Solana</surname>
<given-names>R.</given-names>
</string-name> &amp; <string-name>
<surname>Pawelec</surname>
<given-names>G.</given-names>
</string-name> (<year>1998</year>) <article-title>Molecular and cellular basis of immunosenescence</article-title>. <source xml:lang="en">Mechanisms of Ageing and Development</source>
<volume>102</volume>, <fpage>115</fpage>–<lpage>129</lpage>.<pub-id pub-id-type="pmid">9720646</pub-id></mixed-citation></ref><ref id="vms395-bib-0018"><mixed-citation publication-type="journal" id="vms395-cit-0018">
<string-name>
<surname>Van Maanen</surname>
<given-names>C.</given-names>
</string-name> &amp; <string-name>
<surname>Cullinane</surname>
<given-names>A.</given-names>
</string-name> (<year>2002</year>) <article-title>Equine influenza virus infections: an update</article-title>. <source xml:lang="en">Veterinary Quarterly</source>
<volume>24</volume>, <fpage>79</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="pmid">12095083</pub-id></mixed-citation></ref></ref-list></back></article>